These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26240696)

  • 1. Impact of new technologies on diabetes care.
    Giani E; Scaramuzza AE; Zuccotti GV
    World J Diabetes; 2015 Jul; 6(8):999-1004. PubMed ID: 26240696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus.
    Vigersky RA
    J Diabetes Sci Technol; 2015 Mar; 9(2):320-30. PubMed ID: 25555391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology.
    Lucidi P; Porcellati F; Bolli GB; Fanelli CG
    Curr Diab Rep; 2018 Aug; 18(10):83. PubMed ID: 30121746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern clinical management helps reducing the impact of type 1 diabetes in children.
    Scaramuzza AE; Zuccotti GV
    Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of different glycemic control metrics for optimizing management of diabetes.
    Kohnert KD; Heinke P; Vogt L; Salzsieder E
    World J Diabetes; 2015 Feb; 6(1):17-29. PubMed ID: 25685275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy.
    Scott ES; Fulcher GR; Clifton-Bligh RJ
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 29118986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy.
    Rubin RR; Borgman SK; Sulik BT
    Diabetes Educ; 2011; 37 Suppl 1():5S-18S; quiz 19S-20S. PubMed ID: 21217102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.
    Pease A; Lo C; Earnest A; Liew D; Zoungas S
    Syst Rev; 2018 Mar; 7(1):44. PubMed ID: 29530081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology to Reduce Hypoglycemia.
    Yeoh E; Choudhary P
    J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes.
    Urakami T
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring and pumps.
    Cohen N
    Aust Fam Physician; 2015 May; 44(5):284-7. PubMed ID: 26042400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management.
    Mian Z; Hermayer KL; Jenkins A
    Am J Med Sci; 2019 Nov; 358(5):332-339. PubMed ID: 31402042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.
    Cappon G; Vettoretti M; Sparacino G; Facchinetti A
    Diabetes Metab J; 2019 Aug; 43(4):383-397. PubMed ID: 31441246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
    Martin CT; Criego AB; Carlson AL; Bergenstal RM
    Curr Diab Rep; 2019 Jun; 19(8):50. PubMed ID: 31250124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.